Pharmaceutical composition having site-specific delivery

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61K 49/00 (2006.01)

Patent

CA 2131990

2131990 9317713 PCTABS00025 Use of .alpha.-hydroxy acids and poly-.alpha.-hydroxy acids as spacer between a therapeutically and/or diagnostically active compound and a soluble macromolecular carrier in pharmaceutical compositions having site-specific delivery. In one embodiment glycolic acid, L-lactic acid or tetra-L-lactic acid is used as spacer between a non-steroidal anti-inflammatory substance and a carrier of low molecular protein (LMWP).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition having site-specific delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition having site-specific delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition having site-specific delivery will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1899807

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.